IMURA & Co.,Ltd. (3955) AI Stock Analysis

• Market Cap: ¥9.89B
• Dividend Yield: 3.02%
• Average Volume (3M): 5.57K
• Price to Earnings (P/E): 9.0
• Beta (1Y): 0.38
• Revenue Growth: 6.70%
• EPS Growth: 12.10%
• Country: JP
• Employees: 994
• Sector: Basic Materials
• Sector Strength: 58
• Industry: Industrial Materials
• EPS (TTM): 62.06
• Shares Outstanding: 10,729,370
• 10 Day Avg. Volume: 4,530
• 30 Day Avg. Volume: 5,566
• PEG Ratio: -0.68
• Price to Book (P/B): 0.59
• Price to Sales (P/S): 0.47
• P/FCF Ratio: -76.50
• Enterprise Value/Market Cap: N/A
• Enterprise Value/Revenue: N/A
• Enterprise Value/Gross Profit: N/A
• Enterprise Value/Ebitda: N/A
• 1Y Price Target: N/A
• Price Target Upside: N/A
• Rating Consensus: N/A
• Number of Analyst Covering: 0
• EPS Forecast (FY): N/A
• Revenue Forecast (FY): N/A

• Rating: 79 Outperform
• Price Target: ¥1,136.00 ▲(14.29% Upside)

IMURA & Co., Ltd. receives a strong overall stock score due to its solid financial performance, favorable technical indicators, and attractive valuation. The company's stable balance sheet and low P/E ratio are significant strengths, while technical analysis supports a positive trend. However, attention to revenue growth and capital expenditure management could further enhance its financial health.

Positive Factors

Balance Sheet Health

A strong balance sheet with low leverage enhances financial stability, providing flexibility for strategic investments and resilience against economic downturns.

Operational Cash Flow

Consistent positive operating cash flow supports ongoing operations and investment in growth opportunities, ensuring sustainable business operations.

Profitability

Stable profit margins reflect effective cost management and pricing strategies, contributing to long-term financial health and shareholder value.

Negative Factors

Revenue Growth Challenges

Sluggish revenue growth may indicate market saturation or competitive pressures, potentially limiting future expansion and profitability.

Free Cash Flow Management

Negative free cash flow suggests challenges in managing capital expenditures, which could constrain investment in growth initiatives and impact financial flexibility.

Capital Allocation

Inefficient capital allocation may hinder optimal resource utilization, affecting long-term growth and shareholder returns.

IMURA & Co.,Ltd. Business Overview & Revenue Model

Company Description

IMURA & Co., Ltd. (3955) is a Japanese company specializing in the manufacture and sale of high-performance chemical products, primarily focusing on the fields of pharmaceuticals, cosmetics, and industrial applications. The company is known for its innovative solutions, including specialty chemicals and raw materials that cater to various industries, enhancing product efficacy and performance.

How the Company Makes Money

IMURA & Co., Ltd. generates revenue through the production and sale of its chemical products, which are sold to a diverse range of clients in the pharmaceutical, cosmetic, and industrial sectors. The company’s revenue model is based on direct sales, long-term contracts, and partnerships with other businesses that require specialized chemical formulations. Key revenue streams include bulk sales of raw materials, customized chemical solutions, and licensing agreements for proprietary technologies. Additionally, IMURA & Co., Ltd. benefits from strategic collaborations with research institutions and industry partners, which help to expand its product offerings and market reach, ultimately contributing to its earnings.

IMURA & Co.,Ltd. Financial Statement Overview

Summary

IMURA & Co., Ltd. demonstrates solid financial performance with strong profitability and a stable balance sheet. The income statement indicates good profitability, though revenue growth needs improvement. The balance sheet reflects financial stability with low leverage risk, while cash flow shows strong operational cash flows but concerns about capital expenditure management.

Income Statement

The company shows consistent gross profit margins around 27%, with a slight increase in net profit margin in the latest year, reaching 3.7%. Revenue growth is relatively stable, though there was a recent minor decline. The EBIT and EBITDA margins are steady, reflecting robust operational efficiency. Overall, the income statement indicates good profitability with some room for improvement in revenue growth.

Balance Sheet

The company maintains a strong balance sheet with a low debt-to-equity ratio due to minimal debt levels. The equity ratio is high, indicating solid financial stability. Return on Equity (ROE) is moderate, suggesting efficient use of equity to generate profits. Overall, the balance sheet reflects financial stability and low leverage risk.

Cash Flow

Operating cash flow remains positive, but free cash flow fluctuates, turning negative in the latest period. The operating cash flow to net income ratio is healthy, indicating strong cash generation relative to net income. However, the negative free cash flow highlights potential challenges in managing capital expenditures. Overall, the cash flow statement shows strong operational cash flows with some concerns about capital expenditure management.

Breakdown	TTM	Dec 2024	Dec 2023	Dec 2022	Dec 2021	Dec 2020
Income Statement
Total Revenue	21.93B	20.90B	20.87B	21.74B	20.23B	21.24B
Gross Profit	5.97B	5.64B	5.61B	5.76B	5.14B	5.06B
EBITDA	2.45B	2.11B	2.11B	2.10B	2.04B	1.58B
Net Income	1.09B	771.00M	950.00M	1.02B	994.00M	660.00M
Balance Sheet
Total Assets	24.51B	23.35B	20.56B	19.67B	19.35B	18.67B
Cash, Cash Equivalents and Short-Term Investments	2.86B	2.82B	3.14B	2.76B	3.98B	2.92B
Total Debt	2.04B	2.19B	68.00M	78.00M	89.00M	98.00M
Total Liabilities	6.91B	6.59B	4.33B	4.34B	4.55B	4.61B
Stockholders Equity	17.53B	16.59B	16.21B	15.32B	14.78B	14.05B
Cash Flow
Free Cash Flow	0.00	-128.00M	458.00M	-541.00M	1.00B	856.00M
Operating Cash Flow	0.00	1.71B	1.97B	807.00M	1.56B	1.60B
Investing Cash Flow	0.00	-3.03B	-1.24B	-1.34B	-189.00M	-877.00M
Financing Cash Flow	0.00	1.05B	-314.00M	-694.00M	-325.00M	-101.00M

IMURA & Co.,Ltd. Technical Analysis

• Technical Analysis Sentiment: Positive
• Last Price: 994.00
• 50DMA: Positive
• 100DMA: Positive
• 200DMA: Positive
• MACD: Negative
• RSI: Neutral
• STOCH: Neutral

Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For JP:3955, the sentiment is Positive. The current price of 994 is above the 20-day moving average (MA) of 987.65, above the 50-day MA of 982.38, and above the 200-day MA of 969.56, indicating a bullish trend. The MACD of 2.15 indicates Negative momentum. The RSI at 58.47 is Neutral, neither overbought nor oversold. The STOCH value of 74.72 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for JP:3955.

IMURA & Co.,Ltd. Peers Comparison

Name	Overall Rating	Market Cap	P/E Ratio	ROE	Dividend Yield	Revenue Growth	EPS Growth
3955	79 Outperform	¥9.89B	9.02	―	3.02%	6.70%	12.10%
3945	78 Outperform	¥4.11B	4.13	―	3.35%	1.53%	20.73%
3892	70 Outperform	¥7.87B	9.04	―	3.19%	-2.03%	-23.36%
3895	66 Neutral	¥3.11B	4.71	―	4.42%	-3.73%	-7.14%
Sector *	61 Neutral	$10.43B	7.12	-0.05%	2.87%	2.86%	-36.73%
9929	56 Neutral	¥4.34B	54.21	―	2.65%	-1.03%	-43.05%
3168	52 Neutral	¥8.09B	―	―	3.51%	0.48%	-138.12%